Quipazine

Quipazine
Systematic (IUPAC) name
2-piperazin-1-ylquinoline
Clinical data
Identifiers
4774-24-7 Yes
None
PubChem CID 5011
IUPHAR ligand 173
ChemSpider 4836 
UNII 4WCY05C0SJ 
ChEMBL CHEMBL18772 
Chemical data
Formula C13H15N3
213.278 g/mol
  (what is this?)  (verify)

Quipazine is a piperazine drug used in scientific research. It is a moderately selective serotonin receptor agonist, binding to a range of different serotonin receptors, but particularly to the 5-HT2A[1] and 5-HT3.[2]

See also

References

  1. Smith RL, Barrett RJ, Sanders-Bush E. Neurochemical and behavioral evidence that quipazine-ketanserin discrimination is mediated by serotonin2A receptor. Journal of Pharmacology and Experimental Therapeutics. 1995 Nov;275(2):1050-7. PMID 7473132
  2. Cappelli A, Anzini M, Vomero S, Mennuni L, Makovec F, Doucet E, Hamon M, Bruni G, Romeo MR, Menziani MC, De Benedetti PG, Langer T. Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 1. Mapping the central 5-HT3 receptor binding site by arylpiperazine derivatives. Journal of Medicinal Chemistry. 1998 Feb 26;41(5):728-41. PMID 9513601